A detailed history of Russell Investments Group, Ltd. transactions in Alector, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 72,625 shares of ALEC stock, worth $356,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,625
Previous 83,813 13.35%
Holding current value
$356,588
Previous $380,000 10.79%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.34 - $6.58 $48,555 - $73,617
-11,188 Reduced 13.35%
72,625 $339,000
Q2 2024

Aug 08, 2024

BUY
$4.19 - $6.23 $22,898 - $34,046
5,465 Added 6.98%
83,813 $380,000
Q1 2024

May 08, 2024

BUY
$5.69 - $8.08 $40,205 - $57,093
7,066 Added 9.91%
78,348 $471,000
Q4 2023

Feb 05, 2024

SELL
$3.77 - $8.39 $184,119 - $409,750
-48,838 Reduced 40.66%
71,282 $568,000
Q3 2023

Nov 13, 2023

BUY
$5.2 - $8.77 $104,546 - $176,320
20,105 Added 20.1%
120,120 $778,000
Q2 2023

Aug 10, 2023

SELL
$5.86 - $7.93 $300,307 - $406,388
-51,247 Reduced 33.88%
100,015 $601,000
Q1 2023

May 09, 2023

BUY
$5.85 - $9.84 $227,875 - $383,297
38,953 Added 34.68%
151,262 $936,000
Q4 2022

Feb 08, 2023

BUY
$6.88 - $9.55 $189,846 - $263,522
27,594 Added 32.57%
112,309 $1.04 Million
Q3 2022

Nov 04, 2022

BUY
$8.19 - $13.2 $244,021 - $393,294
29,795 Added 54.25%
84,715 $800,000
Q2 2022

Jul 29, 2022

BUY
$7.65 - $14.24 $342,414 - $637,382
44,760 Added 440.55%
54,920 $557,000
Q4 2021

Jan 21, 2022

BUY
$19.35 - $25.54 $196,596 - $259,486
10,160 New
10,160 $212,000
Q2 2021

Aug 04, 2021

SELL
$15.5 - $22.48 $655,913 - $951,286
-42,317 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$14.84 - $22.23 $378,271 - $566,642
-25,490 Reduced 37.59%
42,317 $852,000
Q4 2020

Feb 08, 2021

SELL
$9.4 - $16.7 $20,614 - $36,623
-2,193 Reduced 3.13%
67,807 $1.03 Million
Q3 2020

Nov 09, 2020

BUY
$10.54 - $24.96 $23,915 - $56,634
2,269 Added 3.35%
70,000 $737,000
Q2 2020

Aug 05, 2020

SELL
$21.87 - $33.11 $448,181 - $678,523
-20,493 Reduced 23.23%
67,731 $1.65 Million
Q1 2020

May 06, 2020

SELL
$16.25 - $35.28 $366,973 - $796,728
-22,583 Reduced 20.38%
88,224 $2.13 Million
Q4 2019

Jan 29, 2020

BUY
$14.17 - $20.3 $679,564 - $973,547
47,958 Added 76.31%
110,807 $1.91 Million
Q3 2019

Nov 01, 2019

BUY
$14.42 - $22.2 $906,282 - $1.4 Million
62,849 New
62,849 $907,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $405M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.